Accelerated Clinical Trial Agreement Template for Singapore

An Accelerated Clinical Trial Agreement is a specialized legal contract that enables rapid deployment of clinical research in Singapore while maintaining compliance with stringent regulatory requirements. This agreement is essential when you need to conduct time-sensitive clinical trials, particularly during public health emergencies or when testing breakthrough treatments that require expedited research timelines.

When do you need this document?

You need an Accelerated Clinical Trial Agreement when conducting urgent clinical research that cannot wait for standard trial setup procedures. This includes emergency use investigations during disease outbreaks, compassionate use programs for critically ill patients, or breakthrough therapy designations requiring rapid clinical validation. The agreement is particularly crucial when multiple parties including sponsors, research institutions, principal investigators, and ethics committees must coordinate quickly while ensuring full regulatory compliance. Public health authorities may also require this agreement structure for pandemic response trials or urgent medical countermeasure studies.

Key legal considerations

Your agreement must clearly define the roles and responsibilities of all parties while addressing accelerated timelines without compromising participant safety or data integrity. Critical clauses include expedited ethics review procedures, streamlined regulatory approval pathways, and modified informed consent processes that comply with emergency research standards. You must carefully address liability allocation between sponsors and institutions, particularly regarding adverse events in accelerated trial settings. Data protection clauses must ensure PDPA compliance for rapid data collection and sharing, while intellectual property provisions should account for collaborative emergency research scenarios. Insurance requirements and indemnification terms require special attention given the heightened risks associated with accelerated research timelines.

Legal requirements in Singapore

Your Accelerated Clinical Trial Agreement must comply with the Human Biomedical Research Act 2015, which governs the conduct of human biomedical research and requires appropriate institutional review board approval even in emergency settings. The Health Products Act mandates HSA notification and approval for investigational products, with specific provisions for emergency use authorizations that may apply to accelerated trials. You must ensure compliance with Singapore's Good Clinical Practice guidelines, which provide standards for trial conduct, data integrity, and participant protection that remain applicable even in expedited scenarios. The Personal Data Protection Act 2012 requires explicit data protection measures, particularly important when rapid data sharing between institutions is necessary. Additionally, your agreement must address reporting requirements to relevant authorities and establish clear communication protocols for safety monitoring and adverse event reporting during accelerated trial conduct.